Lebanon, celebrated for its resilience and vibrant cultural identity, is confronting a quiet yet profound crisis: a decline in life expectancy. This vital indicator of societal well-being has been shifting alarmingly since 2019. Once a point of national pride, the decline in life expectancy now reflects deeper issues—disrupted lives, struggling families, and a healthcare system under strain. At the core of this challenge is rampant inflation, particularly affecting healthcare costs and essential sanitary products, which are indispensable to public health.

The statistics reveal the extent of the issue. Inflation has rendered basic healthcare unaffordable for countless families, pushing medications that were once accessible beyond the financial reach of even middle-class households. Hygiene standards have deteriorated as inflated costs of sanitary products add to public health challenges. UNICEF reports that over 90% of Lebanese families have faced increased medicine prices, with more than half unable to procure essential drugs. Treatable conditions are turning fatal, preventable deaths are rising, and the nation’s life expectancy is eroding as a result.

The depreciation of the Lebanese pound, which has lost 95% of its value, underscores this crisis. Importers are unable to bring in vital medications, and local pharmaceutical production has become prohibitively expensive due to rising costs of raw materials. NGOs such as the Amel Association have stepped in to provide assistance, yet their efforts are insufficient to meet the overwhelming demand. The Union of Drug Manufacturers’ decision to further increase pharmaceutical prices has only deepened the strain on households already battling economic instability.

To address these challenges, Lebanon could adopt a fixed exchange rate mechanism for pharmaceutical pricing. This solution, successfully used in countries like Turkey, separates drug prices from fluctuating currency values, ensuring affordability and stability for consumers and suppliers. Establishing a Price Evaluation Commission to periodically review and adjust the exchange rate would maintain flexibility while protecting patients from abrupt cost increases.

Turkey’s experience offers valuable lessons. By employing a fixed exchange rate for pharmaceuticals, Turkey has shielded its population from the worst impacts of currency devaluation while maintaining drug affordability. Regular rate reviews and government interventions have preserved market stability and ensured continued access to essential medications. Research highlights this approach as an effective framework for balancing affordability with adaptability, making it a viable model for Lebanon’s current economic conditions.

Lebanon’s government must act urgently to stabilize healthcare costs. Implementing a fixed exchange rate mechanism is an essential first step toward ensuring access to affordable medications. This strategy could reverse the decline in life expectancy and strengthen public health systems. The path forward is clear: stabilizing healthcare is not only an economic necessity but a moral obligation to protect Lebanon’s most vulnerable populations and secure a healthier future for all.